SCHEMBL6643602

SCHEMBL6643602

[c]1cccc(-c2ccccc2CNC2CCC2)c1CNCC1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RECQL P46063 1/20 0.41
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
PABPC1 P11940 1/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 2/20 0.34
CXCR4 P61073 1/20 0.33
EBP Q15125 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CD274 Q9NZQ7 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640607 0.77 MEN1 (0.42) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6643605 0.76 MEN1 (0.41) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6636865 0.74 MEN1 (0.43) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL27678126 0.73 KMT2A (0.37) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6322319 0.72 MEN1 (0.37) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6321221 0.72 GPR39 (0.42) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6640137 0.71 KMT2A (0.43) KMT2AMEN1SLC6A2SLC6A4SLC6A3
SCHEMBL6320544 0.70 CYP2D6 (0.35) KMT2AMEN1TP53CYP3A4CYP2D6
SCHEMBL6322714 0.69 KDM4E (0.38) KDM4EALDH1A1HTTCD274PKM
SCHEMBL6325686 0.69 PIM1 (0.41) CYP2D6CYP2C9CYP2C19CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140941-B1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-10-20 EP disclosed
EP-1140941-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000039131-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed